Documentos relacionados

1. Applications of pharmacogenomics in regulatory science: a product life cycle review.
2. Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs.
3. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
4. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
5. Drug Dosing Recommendations for All Patients: A Roadmap for Change.
6. A systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry dates.
7. Towards more reliable automated multi-dose dispensing: retrospective follow-up study on medication dose errors and product defects.
8. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
9. Medicinal products for geriatric patients in Germany : Current status of regulatory requirements and clinical reality.
10. A framework enabling LLMs into regulatory environment for transparency and trustworthiness and its application to drug labeling document.